National Heart Health Month In February

LATHAM, N.Y., Feb. 26, 2015 /PRNewswire/ -- Every year many millions of donations are obtained to support more research to fight heart disease.  Nevertheless, year after year doctors and the medical profession continue to rely on ElectroCardioGrams (EKG) as the first test to determine the status of heart health in all patient, whether they have chest pain or not, even though that technology is over 100 years old,

This occurs despite the fact that doctors know, (while most patients do not know) that EKG's, in most cases, are only 40-50% accurate in determining early signs of heart disease.

Heart disease is our Nations #1 killer, especially in women, and the EKG tests are always the first test.  Why?  Because it is safe, fast and easy to use. However, most of the time patients with chest pain, especially those who come to emergency rooms, eventually find that their pain is not caused by heart disease but is due to a muscle spasm or indigestion, etc.  Yet what happens? – Since EKG is not reliable, nearly all such patients are admitted to the hospital and undergo several more expensive tests, many that are invasive and expose the patients to unnecessary doses of radiation. Because of potential liability, hospitals are reluctant to release patients who may have undetected heart disease because those patients die within 30 days, 

Importantly, to alleviate this and related problems, is a new, exciting and very important alternative test, approaching 100% accuracy for men, women, and children, that is also safe, fast and easy to use, while giving Cardiologists much more meaningful diagnostic results than they can obtain from EKG's. The technology is called MagnetoCardioGraphy (MCG).  Patients presenting themselves with chest pain that is not caused by Heart Disease, can and should be more quickly discharged, avoiding unnecessary costly hospital admissions and further testing after undergoing the 10 minute MCG test.

CardioMag Imaging, Inc. - has, over 14 years, developed this new FDA cleared exciting (MCG) technology.  The test visually and reliably provides cardiologists with an immediate ability to differentiate between normal and abnormal heart function.

Having spent $30 Million to (1) confirm MCG's astounding validity and (2) obtain FDA clearance, as well as a number of patents, the company is now seeking to raise additional capital to commercialize its MCG technology and make it readily available to everybody and achieve enormous savings, in the range of tens of billions of dollars annually to our Nation's HealthCare System.

To expedite the availability of this technology and make it available to forward looking cardiology institutions, CardioMag now has just a few systems available for acquisition by these entities, at a cost lower than MCG equipment.

For more information – go to www.cardiomag.com.

OR

CONTACT:     Carl H. Rosner, Chairman and CEO

E-mail Address:   [email protected]

Phone (518) 381-1000

Safe Harbor Statement:  The statements presented in this press release which are not historical facts are forward looking statements which involve various important assumptions, risks, uncertainties and other factors set forth here, including but not limited to, market acceptance by healthcare providers, obtaining FDA approval for future claims, insurance reimbursement policies, and growth of the market.

SOURCE CardioMag Imaging, Inc.

Related Links

http://www.cardiomag.com